Thermo Fisher launches LDT to support tailored immunosuppressant dosing
Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.
02 March 2026
02 March 2026
Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.